ConductScience.org, home

Paper36979861

From NAFLD to MAFLD: Definition, Pathophysiological Basis and Cardiovascular Implications.

Boccatonda A and 8 others. Biomedicines, 2023. Cited by 91 papers, by iCite.

Cite this record

ConductScience Library. From NAFLD to MAFLD: Definition, Pathophysiological Basis and Cardiovascular Implications. Papers, record 36979861. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36979861

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
From NAFLD to MAFLD: Definition, Pathophysiological Basis and Cardiovascular Implications.
PubMed
Journal
Biomedicines
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
91
iCite
Relative citation ratio, by iCite
12.1
iCite
Revised in PubMed
2023-03-31
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Boccatonda AAndreahttps://orcid.org/0000-0001-9303-7790
2Andreetto LLorenzo
3D'Ardes DDamianohttps://orcid.org/0000-0001-5573-4536
4Cocco GGiuliohttps://orcid.org/0000-0003-3458-5468
5Rossi IIlariahttps://orcid.org/0000-0001-5163-9929
6Vicari SSusanna
7Schiavone CCosima
8Cipollone FFrancesco
9Guagnano MTMaria Teresahttps://orcid.org/0000-0001-7225-0891

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT06585982Synbiotics Impact on Insulin and TNF-α in MAFLD: a Gut Microbiota Profile AnalysisBackground

Source ClinicalTrials.gov

Download CSV of trials

References102

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111961152Nonalcoholic fatty liver disease.N Engl J Med2002https://conductscience.org/library/papers/11961152PubMed
235639744A significant risk of metabolic dysfunction-associated fatty liver disease plus diabetes on subclinical atherosclerosis.PLoS One2022https://conductscience.org/library/papers/35639744PubMed
327072166Oxidative Stress Modulation Through Habitual Physical Activity.Curr Pharm Des2016https://conductscience.org/library/papers/27072166PubMed
429981771An Overview and Update on Obesity and the Obesity Paradox in Cardiovascular Diseases.Prog Cardiovasc Dis2018https://conductscience.org/library/papers/29981771PubMed
518317565Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice.J Clin Invest2008https://conductscience.org/library/papers/18317565PubMed
632707340Association of Hepatic Steatosis With Major Adverse Cardiovascular Events, Independent of Coronary Artery Disease.Clin Gastroenterol Hepatol2021https://conductscience.org/library/papers/32707340PubMed
733162743Association between cardiac conduction defect and nonalcoholic fatty liver disease: a systematic review and meta-analysis.Ann Gastroenterol2020https://conductscience.org/library/papers/33162743PubMed
827732328Effect of Liraglutide Therapy on Liver Fat Content in Patients With Inadequately Controlled Type 2 Diabetes: The Lira-NAFLD Study.J Clin Endocrinol Metab2017https://conductscience.org/library/papers/27732328PubMed
930079133Associations between nonalcoholic fatty liver disease and ischemic stroke.World J Hepatol2018https://conductscience.org/library/papers/30079133PubMed
1030731283Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps.Atherosclerosis2019https://conductscience.org/library/papers/30731283PubMed
1115920069Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in asian diabetic patients? Analysis from the Japan Diabetes Complications Study.Diabetes Care2005https://conductscience.org/library/papers/15920069PubMed
1231965072Liraglutide improves memory in obese patients with prediabetes or early type 2 diabetes: a randomized, controlled study.Int J Obes (Lond)2020https://conductscience.org/library/papers/31965072PubMed
1326044182Arterial stiffness and sedentary lifestyle: Role of oxidative stress.Vascul Pharmacol2016https://conductscience.org/library/papers/26044182PubMed
1433530440NAFLD and Cardiovascular Diseases: Epidemiological, Mechanistic and Therapeutic Considerations.J Clin Med2021https://conductscience.org/library/papers/33530440PubMed
1515920328Should nonalcoholic fatty liver disease be renamed?Dig Dis2005https://conductscience.org/library/papers/15920328PubMed
1630122305
Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial.
Lancet2018https://conductscience.org/library/papers/30122305PubMed
1735693392Is it necessary to target lipid metabolism in different organs for effective treatment of NASH?-the results of the Pan-PPAR Lanifibranor trial.Hepatobiliary Surg Nutr2022https://conductscience.org/library/papers/35693392PubMed
1836577468Blood pressure stratification for predicting liver fibrosis risk in metabolic dysfunction associated fatty liver disease.Ann Hepatol2023https://conductscience.org/library/papers/36577468PubMed
1933038502
A randomised, double-blind, placebo-controlled, multi-centre, dose-range, proof-of-concept, 24-week treatment study of lanifibranor in adult subjects with non-alcoholic steatohepatitis: Design of the NATIVE study.
Contemp Clin Trials2020https://conductscience.org/library/papers/33038502PubMed
2031455011Cardiovascular Risk in Non-Alcoholic Fatty Liver Disease: Mechanisms and Therapeutic Implications.Int J Environ Res Public Health2019https://conductscience.org/library/papers/31455011PubMed

See all 102 referencesDownload CSV of references

Cited by73

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 91 citations.

PMIDTitleJournalYearIn PapersSource
42789307An RNA thermogenic therapy to preserve lean mass and enhance metabolic health during GLP-1 weight loss.Proc Natl Acad Sci U S A2026https://conductscience.org/library/papers/42789307PubMed
42665350Perspectives of gastroenterologists on the evolving epidemiology and management of non-alcoholic fatty liver disease in Pakistan: a qualitative study.BMJ Open2026https://conductscience.org/library/papers/42665350PubMed
42290708Association of prediabetes phenotypes with metabolic dysfunction-associated fatty liver disease and liver fibrosis: a population-based study.Ther Adv Endocrinol Metab2026https://conductscience.org/library/papers/42290708PubMed
42075067Effect of 4-Week Consumption of "Navelina" Oranges on Serum Lipid Profile in Patients with MASLD: Evidence from a Randomized Clinical Trial.Nutrients2026https://conductscience.org/library/papers/42075067PubMed
41972947Plasma proteome profiling identifies XPNPEP3 as a novel biomarker associated with metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus.Ann Med2026https://conductscience.org/library/papers/41972947PubMed
41915720Large language model detects previously undiagnosed heart failure with preserved ejection fraction in patients with metabolic-associated fatty liver disease: A multicenter cohort study.PLOS Digit Health2026https://conductscience.org/library/papers/41915720PubMed
41828076Rare Causes of Portal Vein Thrombosis and Occlusion: A Narrative Review.Diagnostics (Basel)2026https://conductscience.org/library/papers/41828076PubMed
41728070MetALD: decoding the evolution of steatotic liver disease nomenclature and implications for clinical practice and beyond.Gastroenterol Rep (Oxf)2026https://conductscience.org/library/papers/41728070PubMed
41718836Metabolomic characteristics and mechanisms of subgingival plaque in MASLD patients with periodontitis.Metabolomics2026https://conductscience.org/library/papers/41718836PubMed
41590615Antioxidant Clove Extract Inhibits Lipid Droplet Accumulation and Lipid Oxidation in Hepatocytes.Metabolites2025https://conductscience.org/library/papers/41590615PubMed
41479860Pathophysiology of depression and anxiety in metabolic dysfunction-associated steatotic liver disease.World J Gastrointest Pathophysiol2025https://conductscience.org/library/papers/41479860PubMed
41295331Serum Extracellular Vesicles as Pathogenetic Signals in Obese and Lean Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease.Metabolites2025https://conductscience.org/library/papers/41295331PubMed
41245406The non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is associated with early onset type 2 diabetes with NAFLD: a cross-sectional study in China.Front Nutr2025https://conductscience.org/library/papers/41245406PubMed
41100462Nonlinear association between TyG-BMI and MAFLD: A cross-sectional study.PLoS One2025https://conductscience.org/library/papers/41100462PubMed
40954485Screening for metabolic-associated fatty liver disease in type 2 diabetes patients using non-invasive scores and ultrasound: a cross-sectional study in Egypt.BMC Gastroenterol2025https://conductscience.org/library/papers/40954485PubMed
40897824A potential age-independent MASLD-related liver fibrosis index based on metabolic profiling.Sci Rep2025https://conductscience.org/library/papers/40897824PubMed
40886507Exposure to low levels of hexavalent chromium in drinking water alters diet-induced steatotic liver disease in male rats.J Trace Elem Med Biol2025https://conductscience.org/library/papers/40886507PubMed
40863135Whey Proteins and Metabolic Dysfunction-Associated Steatotic Liver Disease Features: Evolving the Current Knowledge and Future Trends.Metabolites2025https://conductscience.org/library/papers/40863135PubMed
40860752MAFLD: A Comprehensive Review of the Link Between Metabolic Dysfunction and Cardiovascular Risk.Hepat Med2025https://conductscience.org/library/papers/40860752PubMed
40842749Detecting Portal Venous Blood Flow in Metabolic Dysfunction-Associated Fatty Liver Disease Using Non-Invasive Doppler Ultrasound.Cureus2025https://conductscience.org/library/papers/40842749PubMed

See all 73 cited byDownload CSV of cited by

Genes25

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ACACA31PubTator's text mininghttps://conductscience.org/library/genes/31NCBI Gene
ANGPTL327329PubTator's text mininghttps://conductscience.org/library/genes/27329NCBI Gene
ANGPTL451129PubTator's text mininghttps://conductscience.org/library/genes/51129NCBI Gene
CRP1401PubTator's text mininghttps://conductscience.org/library/genes/1401NCBI Gene
EDN11906PubTator's text mininghttps://conductscience.org/library/genes/1906NCBI Gene
FASN2194PubTator's text mininghttps://conductscience.org/library/genes/2194NCBI Gene
FGB2244PubTator's text mininghttps://conductscience.org/library/genes/2244NCBI Gene
FGF2126291PubTator's text mininghttps://conductscience.org/library/genes/26291NCBI Gene
GCG2641PubTator's text mininghttps://conductscience.org/library/genes/2641NCBI Gene
GGT12678PubTator's text mininghttps://conductscience.org/library/genes/2678NCBI Gene
GLP1R2740PubTator's text mininghttps://conductscience.org/library/genes/2740NCBI Gene
IGF13479PubTator's text mininghttps://conductscience.org/library/genes/3479NCBI Gene
INS3630PubTator's text mininghttps://conductscience.org/library/genes/3630NCBI Gene
LPL4023PubTator's text mininghttps://conductscience.org/library/genes/4023NCBI Gene
NR1H49971PubTator's text mininghttps://conductscience.org/library/genes/9971NCBI Gene
PCSK9255738PubTator's text mininghttps://conductscience.org/library/genes/255738NCBI Gene
PPARA5465PubTator's text mininghttps://conductscience.org/library/genes/5465NCBI Gene
PPARG5468PubTator's text mininghttps://conductscience.org/library/genes/5468NCBI Gene
SERPINE15054PubTator's text mininghttps://conductscience.org/library/genes/5054NCBI Gene
SLC17A526503PubTator's text mininghttps://conductscience.org/library/genes/26503NCBI Gene

See all 25 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36979861

GET https://conductscience.org/api/papers/v1/36979861/references?page=2